Coinciding with a few new business wins, recent recognition at the Pharmacy Awards and the promotion of Robin Powell to creative director, BCG2 has expanded its creative department with four new arrivals: Alex Dyer, Anita Young, Matthias May and Matt Watts.
Browsing: Stuart Ogden
BCG2 Health appears to be revelling in its niche at the moment after a couple of good wins and it’s toasting to more good health because, after a competitive pitch, Fisher and Paykel Healthcare has shacked up with the agency to launch a digital consumer and trade campaign in the US, a key market for its range of sleep apnoea medical devices.
BCG2 Health’s Pfizer ‘FACTORy’ programme, originally developed in New Zealand in collaboration with Spitfire, and then launched into Australia, has won a Pfizer Human Health global award for commercial excellence and innovation.
bcg2 Health and Spitfire have snaffled a couple more Pfizer brands, after the two combined forces to win the haemophilia treatments pitch for the Xyntha and BeneFIX products in the Australian market against two Aussie agencies. This win adds to the New Zealand haemophilia business that was won in November last year.